AU2020224678B2 - Solid polymorphs of a FLNA-binding compound and its hydrochloride salts - Google Patents

Solid polymorphs of a FLNA-binding compound and its hydrochloride salts Download PDF

Info

Publication number
AU2020224678B2
AU2020224678B2 AU2020224678A AU2020224678A AU2020224678B2 AU 2020224678 B2 AU2020224678 B2 AU 2020224678B2 AU 2020224678 A AU2020224678 A AU 2020224678A AU 2020224678 A AU2020224678 A AU 2020224678A AU 2020224678 B2 AU2020224678 B2 AU 2020224678B2
Authority
AU
Australia
Prior art keywords
crystalline
peaks
ray powder
powder diffraction
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020224678A
Other languages
English (en)
Other versions
AU2020224678A1 (en
Inventor
Lindsay Burns Barbier
Shawn Anthony Kucera
Michael Zamloot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pain Therapeutics Inc
Original Assignee
Pain Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pain Therapeutics Inc filed Critical Pain Therapeutics Inc
Publication of AU2020224678A1 publication Critical patent/AU2020224678A1/en
Application granted granted Critical
Publication of AU2020224678B2 publication Critical patent/AU2020224678B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2020224678A 2019-02-21 2020-02-21 Solid polymorphs of a FLNA-binding compound and its hydrochloride salts Active AU2020224678B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962808609P 2019-02-21 2019-02-21
US62/808,609 2019-02-21
PCT/US2020/019305 WO2020172584A1 (en) 2019-02-21 2020-02-21 Solid polymorphs of a flna-binding compound and its hydrochloride salts

Publications (2)

Publication Number Publication Date
AU2020224678A1 AU2020224678A1 (en) 2021-09-16
AU2020224678B2 true AU2020224678B2 (en) 2024-03-14

Family

ID=72141575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020224678A Active AU2020224678B2 (en) 2019-02-21 2020-02-21 Solid polymorphs of a FLNA-binding compound and its hydrochloride salts

Country Status (10)

Country Link
US (4) US11370791B2 (https=)
EP (1) EP3927707A4 (https=)
JP (2) JP2022523196A (https=)
KR (1) KR20210135530A (https=)
CN (2) CN114072406B (https=)
AU (1) AU2020224678B2 (https=)
BR (1) BR112021016622A2 (https=)
CA (1) CA3131146A1 (https=)
IL (1) IL285763A (https=)
WO (1) WO2020172584A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020172584A1 (en) 2019-02-21 2020-08-27 Pain Therapeutics, Inc. Solid polymorphs of a flna-binding compound and its hydrochloride salts
US20220233512A1 (en) * 2020-11-03 2022-07-28 Cassava Sciences, Inc. Inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8653068B2 (en) * 2009-10-30 2014-02-18 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014304A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen
US9340558B2 (en) * 2007-11-02 2016-05-17 Pain Therapeutics Inc. Filamin a binding anti-inflammatory and analgesic
US8614324B2 (en) * 2008-10-31 2013-12-24 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
WO2010051497A1 (en) * 2008-10-31 2010-05-06 Pain Therapeutics, Inc. Filamin a binding anti-inflammatory and analgesic
EP2549873A1 (en) * 2010-03-25 2013-01-30 Merck Sharp & Dohme Corp. Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use
WO2014012054A1 (en) 2012-07-13 2014-01-16 Pain Therapeutics, Inc. Alzheimer's disease assay in a living patent
EP2882428B1 (en) * 2012-07-13 2019-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation
US9433604B2 (en) * 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
WO2020172584A1 (en) 2019-02-21 2020-08-27 Pain Therapeutics, Inc. Solid polymorphs of a flna-binding compound and its hydrochloride salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8653068B2 (en) * 2009-10-30 2014-02-18 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic

Also Published As

Publication number Publication date
JP2022523196A (ja) 2022-04-21
WO2020172584A1 (en) 2020-08-27
US12391693B2 (en) 2025-08-19
AU2020224678A1 (en) 2021-09-16
US20240400566A1 (en) 2024-12-05
JP2024054139A (ja) 2024-04-16
US20220340574A1 (en) 2022-10-27
CN114072406B (zh) 2025-03-18
EP3927707A4 (en) 2022-11-09
US12065440B2 (en) 2024-08-20
US11370791B2 (en) 2022-06-28
US20200270250A1 (en) 2020-08-27
CN114072406A (zh) 2022-02-18
CN120004896A (zh) 2025-05-16
NZ779310A (en) 2024-01-26
BR112021016622A2 (pt) 2021-11-03
IL285763A (en) 2021-10-31
EP3927707A1 (en) 2021-12-29
KR20210135530A (ko) 2021-11-15
CA3131146A1 (en) 2020-08-27
US20250084083A1 (en) 2025-03-13

Similar Documents

Publication Publication Date Title
US12391693B2 (en) Solid polymorphs of a FLNA-binding compound and its hydrochloride salts
JP2020100624A (ja) Ｌ−オルニチンフェニルアセテートおよびその製造方法
US20250161292A1 (en) Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
US10023566B2 (en) Dasatinib salts
US10556896B2 (en) Crystalline forms of (3-Amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine
US20250243223A1 (en) Solid state forms of ixazomib citrate
US20230286938A1 (en) Polymorphs of a dihydroorotate dehydrogenase (dhod) inhibitor
KR20240019116A (ko) (3r)-n-[2-시아노-4-플루오로-3-(3-메틸-4-옥소-퀴나졸린-6-일)옥시-페닐]-3-플루오로-피롤리딘-1-설폰아미드의신규 고체 형태
IL259556B2 (en) Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
RU2597423C2 (ru) Бензойнокислая соль отамиксабана
US20200347069A1 (en) Novel crystal form of acalabrutinib and preparation method and use thereof
WO2020025449A1 (en) Highly stable crystalline eltrombopag monoethanolamine salt form d1
US9643950B2 (en) Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
US20230105181A1 (en) Salts and polymorphic forms of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1h-pyrazol-4-yl)-3h-imidazo[4,5-b]pyridine
WO2026072992A1 (en) Salts and solid forms of muscarinic receptor agonists
TW202415667A (zh) (S)-7-氧雜-2-氮雜-螺[4.5]癸烷-2-甲酸[7-(3,6-二氫-2H-吡喃-4-基)-4-甲氧基-噻唑并[4,5-c]吡啶-2-基]-醯胺之新穎結晶型及其共晶型